BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31810132)

  • 1. Total saponins from Paris forrestii (Takht) H. Li. show the anticancer and RNA expression regulating effects on prostate cancer cells.
    Xia C; Chen L; Sun W; Yan R; Xia M; Wang Y; Yang D
    Biomed Pharmacother; 2020 Jan; 121():109674. PubMed ID: 31810132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of Paris Forrestii (Takht.) H. Li-Suppressing the Proliferation of Acute Myeloid Leukemia Cell Lines].
    Lu Q; Zheng YJ; Hu YX; Wang YH; Mao XL; Hu SY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):7-13. PubMed ID: 30738440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituting one Paris for another? In vitro cytotoxic and in vivo antitumor activities of Paris forrestii, a substitute of Paris polyphylla var. yunnanensis.
    Wang YH; Shi M; Niu HM; Yang J; Xia MY; Luo JF; Chen YJ; Zhou YP; Li H
    J Ethnopharmacol; 2018 May; 218():45-50. PubMed ID: 29454914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Saponins from Paris forrestii Reverse Multidrug Resistance of MCF-7/ADM Cells by Suppression of P-gp via ERK Signaling Pathway.
    Chai D; Yuan J; Zhu X; Zeng Y; Yang R; Chen Y; Wang Y; Zhou Y
    Biol Pharm Bull; 2020 Dec; 43(12):1823-1830. PubMed ID: 32963175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
    Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
    Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA TUG1 regulates prostate cancer cell proliferation, invasion and migration via the Nrf2 signaling axis.
    Yang G; Yin H; Lin F; Gao S; Zhan K; Tong H; Tang X; Pan Q; Gou X
    Pathol Res Pract; 2020 Apr; 216(4):152851. PubMed ID: 32057513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.
    Chiyomaru T; Yamamura S; Fukuhara S; Yoshino H; Kinoshita T; Majid S; Saini S; Chang I; Tanaka Y; Enokida H; Seki N; Nakagawa M; Dahiya R
    PLoS One; 2013; 8(8):e70372. PubMed ID: 23936419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
    Zhou R; Lu Z; Liu K; Guo J; Liu J; Zhou Y; Yang J; Mi M; Xu H
    Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b.
    Zhang JJ; Zhou XH; Zhou Y; Wang YG; Qian BZ; He AN; Shen Z; Hu HY; Yao Y
    Acta Pharmacol Sin; 2019 Sep; 40(9):1228-1236. PubMed ID: 31028291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saponins From
    Lu Q; He Y; Wang Y; Gao L; Zheng Y; Zhang Z; Cao B; Wang Q; Mao X; Hu S
    Front Pharmacol; 2018; 9():673. PubMed ID: 29997504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crude saponins from Platycodon grandiflorum induce apoptotic cell death in RC-58T/h/SA#4 prostate cancer cells through the activation of caspase cascades and apoptosis-inducing factor.
    Lee JH; Oh EK; Cho HD; Kim JY; Lee MK; Seo KI
    Oncol Rep; 2013 Apr; 29(4):1421-8. PubMed ID: 23443329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
    Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
    Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.